Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromocriptine versus cabergoline for pregnancy achievement in hyperprolactinemic infertile women
IRCT138806142420N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Mar 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of bromocriptine and cabergoline in hyperprolactinemia and female infertility (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Occurrence of pregnancy. Started Mar 2005; status: completed.
02
Drugs
bromocriptinecabergoline
03
Conditions
hyperprolactinemiafemale infertility
Beyond the preview
Go deeper on IRCT138806142420N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138806142420N1.